These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 16451335)

  • 1. Editorial: Global elimination of lymphatic filariasis: fact or fantasy?
    Gyapong JO; Twum-Danso NA
    Trop Med Int Health; 2006 Feb; 11(2):125-8. PubMed ID: 16451335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphatic filariasis elimination in the Pacific: PacELF replicating Japanese success.
    Ichimori K; Graves PM; Crump A
    Trends Parasitol; 2007 Jan; 23(1):36-40. PubMed ID: 17126604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis.
    Gustavsen KM; Bradley MH; Wright AL
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S11-5. PubMed ID: 19843393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000-2007).
    Hooper PJ; Bradley MH; Biswas G; Ottesen EA
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S17-21. PubMed ID: 19843394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic filariasis in the Eastern Mediterranean Region: current status and prospects for elimination.
    El Setouhy M; Ramzy RM
    East Mediterr Health J; 2003 Jul; 9(4):534-41. PubMed ID: 15748050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass drug administration to eliminate lymphatic filariasis in India.
    Ramaiah KD; Das PK
    Trends Parasitol; 2004 Nov; 20(11):499-502. PubMed ID: 15471698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic filariasis: Treatment, control and elimination.
    Ottesen EA
    Adv Parasitol; 2006; 61():395-441. PubMed ID: 16735170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress towards, and challenges for, the elimination of filariasis from Pacific-island communities.
    Burkot TR; Taleo G; Toeaso V; Ichimori K
    Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S61-9. PubMed ID: 12625919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eliminating lymphatic filariasis--the surveillance challenge.
    Huppatz C; Durrheim D; Lammie P; Kelly P; Melrose W
    Trop Med Int Health; 2008 Mar; 13(3):292-4. PubMed ID: 18397392
    [No Abstract]   [Full Text] [Related]  

  • 10. [ Bancroftian lymphatic filariasis: toward its elimination from the Pacific?].
    Chanteau S; Roux JF
    Bull Soc Pathol Exot; 2008 Jun; 101(3):254-60. PubMed ID: 18681220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress towards eliminating lymphatic filariasis in Zanzibar: a model programme.
    Mohammed KA; Molyneux DH; Albonico M; Rio F
    Trends Parasitol; 2006 Jul; 22(7):340-4. PubMed ID: 16713740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How endemic countries can accelerate lymphatic filariasis elimination? An analytical review to identify strategic and programmatic interventions.
    Lahariya C; Tomar SS
    J Vector Borne Dis; 2011 Mar; 48(1):1-6. PubMed ID: 21406730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global programme to eliminate lymphatic filariasis: progress report, 2011.
    Wkly Epidemiol Rec; 2012 Sep; 87(37):346-56. PubMed ID: 22977953
    [No Abstract]   [Full Text] [Related]  

  • 14. The sharp end - experiences from the Tanzanian programme for the elimination of lymphatic filariasis: notes from the end of the road.
    Malecela MN; Mwingira U; Mwakitalu ME; Kabali C; Michael E; Mackenzie CD
    Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S53-7. PubMed ID: 19843398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic filariasis in Papua New Guinea: prospects for elimination.
    Bockarie MJ; Kazura JW
    Med Microbiol Immunol; 2003 Feb; 192(1):9-14. PubMed ID: 12592558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Global Programme to eliminate lymphatic filariasis: progress report on mass drug administration, 2010.
    Wkly Epidemiol Rec; 2011 Aug; 86(35):377-88. PubMed ID: 21887884
    [No Abstract]   [Full Text] [Related]  

  • 17. Managing morbidity and preventing disability in the Global Programme to Eliminate Lymphatic Filariasis: WHO position statement.
    Wkly Epidemiol Rec; 2011 Dec; 86(51-52):581-5. PubMed ID: 22191103
    [No Abstract]   [Full Text] [Related]  

  • 18. Towards a strategic plan for research to support the global program to eliminate lymphatic filariasis. Summary of Immediate needs and opportunities for research on lymphatic filariasis. Philadelphia, Pennsylvania, USA, December 9-10, 2003.
    Am J Trop Med Hyg; 2004 Nov; 71(5 Suppl):iii, 1-46. PubMed ID: 15574967
    [No Abstract]   [Full Text] [Related]  

  • 19. Sharing the burden of TB/HIV? Costs and financing of public-private partnerships for tuberculosis treatment in South Africa.
    Sinanovic E; Kumaranayake L
    Trop Med Int Health; 2006 Sep; 11(9):1466-74. PubMed ID: 16930269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global programme to eliminate lymphatic filariasis: progress report for 2012.
    Wkly Epidemiol Rec; 2013 Sep; 88(37):389-99. PubMed ID: 24073461
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.